These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27495200)

  • 1. Treatment of Advanced Parkinson Disease and Related Disorders.
    Miyasaki JM
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1104-16. PubMed ID: 27495200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy.
    Wiblin L; Lee M; Burn D
    Parkinsonism Relat Disord; 2017 Jan; 34():7-14. PubMed ID: 28341224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative care in Parkinson disease and related disorders.
    Corcoran J; Huang AH; Miyasaki JM; Tarolli CG
    Handb Clin Neurol; 2023; 191():107-128. PubMed ID: 36599503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.
    McFarland NR; Hess CW
    Semin Neurol; 2017 Apr; 37(2):215-227. PubMed ID: 28511262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson-plus patients--an unknown group with severe symptoms.
    Sjöström AC; Holmberg B; Strang P
    J Neurosci Nurs; 2002 Dec; 34(6):314-9. PubMed ID: 12506814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional trials in atypical parkinsonism.
    Eschlböck S; Krismer F; Wenning GK
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S82-92. PubMed ID: 26421389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of repeated administrations of granulocyte colony stimulating factor for blood stem cells mobilization in patients with progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy.
    Pezzoli G; Tesei S; Canesi M; Sacilotto G; Vittorio M; Mizuno Y; Mochizuki H; Antonini A
    Clin Neurol Neurosurg; 2010 Jan; 112(1):65-7. PubMed ID: 19765889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical Parkinson syndromes--recent advances in diagnosis and therapy].
    Duerr S; Wenning GK; Seppi K; Poewe W
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):492-500. PubMed ID: 22457226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
    Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
    Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.
    Holden SK; Koljack CE; Prizer LP; Sillau SH; Miyasaki JM; Kluger BM
    Parkinsonism Relat Disord; 2019 Aug; 65():172-177. PubMed ID: 31253494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.
    Poewe W; Mahlknecht P; Krismer F
    Mov Disord; 2015 Sep; 30(11):1528-38. PubMed ID: 26227071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parkinson's disease and atypical Parkinson syndromes].
    Lorenzl S
    MMW Fortschr Med; 2009 Dec; 151(51-52):39-40. PubMed ID: 20088320
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions.
    Saleem TZ; Higginson IJ; Chaudhuri KR; Martin A; Burman R; Leigh PN
    Palliat Med; 2013 Sep; 27(8):722-31. PubMed ID: 23208011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
    Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
    Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain in Extrapyramidal Neurodegenerative Diseases.
    Yust-Katz S; Hershkovitz R; Gurevich T; Djaldetti R
    Clin J Pain; 2017 Jul; 33(7):635-639. PubMed ID: 27623111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance.
    Christine CW; Aminoff MJ
    Am J Med; 2004 Sep; 117(6):412-9. PubMed ID: 15380498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
    Stamelou M; Quinn NP; Bhatia KP
    Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
    Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
    Wenning GK; Colosimo C
    Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual signs and symptoms of corticobasal degeneration.
    Armstrong RA
    Clin Exp Optom; 2016 Nov; 99(6):498-506. PubMed ID: 27553583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.